Use of fixed autologous stimulator cells to correctly present human immunodeficiency virus type 1 viral peptides to nonhuman primate lymphocytes in proliferation and cytotoxic T-lymphocyte assays.

Munroe, K J; Anderson, C A; Wu, J Y; Wyand, M S; Newman, G W; Newman, M J

Munroe, K J; Anderson, C A; Wu, J Y; Wyand, M S; Newman, G W; Newman, M J.

Affiliation

Munroe KJ; Cambridge Biotech Corporation, Worcester, Massachusetts 01605, USA.

Clin Diagn Lab Immunol ; 1(3): 283-9, 1994 May.

Article in En | MEDLINE | ID: mdl-7496963

Subject(s)

Antigen-Presenting Cells/immunology; Cytotoxicity Tests, Immunologic; HIV-1/immunology; Lymphocyte Activation; Amino Acid Sequence; Animals; Antigen Presentation; Cell Transformation, Viral; Epitopes/immunology; Fixatives/pharmacology; Glutaral/pharmacology; HIV Envelope Protein gp120; Lymphocyte Activation/drug effects; Lymphocyte Culture Test, Mixed; Macaca mulatta; Molecular Sequence Data; T-Lymphocytes, Cytotoxic/immunology; Vaccinia virus/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Cytotoxicity Tests, Immunologic / Lymphocyte Activation / HIV-1 / Antigen-Presenting Cells Limits: Animals Language: En Journal: Clin Diagn Lab Immunol Journal subject: ALERGIA E IMUNOLOGIA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Year: 1994 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google